cenegermin: Clinical Trials

4 trials of cenegermin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Recruiting 2

Follow cenegermin: new trials by email Literature Review of cenegermin trials Research Report on cenegermin

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Cenegermin, Vehicle - Non-Arteritic Anterior Ischemic Optic Neuropathy
Phase 3RecruitingDompé Farmaceutici S.p.A2722026-07-012026-10-27
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Cenegermin, Vehicle - Persistent Corneal Epithelial Defect
Phase 3RecruitingDompé Farmaceutici S.p.A1502026-06-022026-10-07
Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease
Cenegermin, Vehicle - Dry Eye Disease
Phase 3CompletedDompé Farmaceutici S.p.A852022-01-272025-11-26
Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study)
Oxervate, Vehicle - Dry Eye
Phase 3CompletedDompé Farmaceutici S.p.A1042022-01-192024-06-07

Conditions studied

Dry Eye Syndromes (2)  ·  Conjunctivitis, Allergic (1)  ·  Optic Nerve Diseases (1)  ·  Optic Neuropathy, Ischemic (1)

Sponsors

Dompé Farmaceutici S.p.A (4)

Countries

United States (4)  ·  Italy (3)  ·  South Korea (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Australia (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Japan (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

Flavio Mantelli, MD (2)

NIH funding

2025 (1)